Please assess the completion status of the following clinical trial:

Trial Title: Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically proven adenocarcinoma of the stomach.~* Surgical resectable carcinoma (T1-4b, N1-3) (table 1)~* Pathological proven peritoneal metastases~* Peritoneal Cancer Index (PCI) ≤12~* WHO performance status 0,1 or 2 and ASA 1-3~* Age ≥ 18~* Written informed consent~Exclusion Criteria:~* Distant metastases other than peritoneal metastases~* Siewert type I/II gastro-esophageal junction tumor 22.~* Peritoneal carcinomatosis as a presentation of recurrent disease~* Pregnancy~* Any contraindication to cisplatin, e.g.~  * Hypersensitivity~ * HIV infection~ * inadequate bone marrow function (ANC \<1.5x109/L or Platelets \<100x109/L)~ * inadequate hepatic function (\>1.5 x ULN, ALAT and ASAT \>2.5 x ULN)~ * inadequate renal function (Creatinine clearance \<50 ml/min)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Study population (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).